https://www.statcounter.com/counter/counter.js
Web Analytics
Home » Posts tagged with » Gene therapy company
Castle Creek to acquire cell and gene therapy company Fibrocell

Castle Creek to acquire cell and gene therapy company Fibrocell

Castle Creek acquisition of Fibrocell : Castle Creek Pharmaceutical Holdings (CCP Holdings) has agreed to acquire Fibrocell Science, a cell and gene therapy company engaged in developing autologous cell-based therapies for skin and connective tissue disorders. Financial terms of the deal were not disclosed, as per the latest pharma industry news. CCP Holdings is a […]

US gene therapy company Renovacor raises $11m for BAG3 gene therapy

US gene therapy company Renovacor, which is engaged in developing BAG3 gene therapy and other gene therapies for cardiovascular disease, has raised $11 million through a Series A financing round led jointly by Novartis Venture Fund, Broadview Ventures, and BioAdvance. New Leaf Venture Partners and Innogest Capital also joined the Series A funding round. The […]

Continue reading …
Apic Bio bags FDA orphan designation for ALS SOD1 gene therapy APB-102

US gene therapy company Apic Bio said that APB-102, its ALS SOD1 gene therapy, has been granted orphan drug designation by the US Food and Drug Administration (FDA). APB-102 is expected to shortly enter into clinical development for the genetic disorder – SOD1 amyotrophic lateral sclerosis (ALS). The orphan designation is given to novel drugs […]

Continue reading …
Biogen to acquire UK gene therapy company Nightstar Therapeutics for $800m

Biogen acquisition of Nightstar Therapeutics : US biotech company Biogen has signed a deal of $800 million to acquire Nightstar Therapeutics, a British clinical-stage gene therapy company, as per the latest pharma acquisition news. Nightstar Therapeutics primarily focuses on the developing adeno-associated virus (AAV) treatments for inherited retinal disorders. Biogen acquisition of Nightstar Therapeutics According […]

Continue reading …
Roche in $4.3bn deal to buy gene therapy company Spark Therapeutics

Roche acquisition of Spark Therapeutics : Swiss pharma giant Roche has signed an all-cash deal worth $4.3 billion to acquire US gene therapy company Spark Therapeutics, as per the latest pharma acquisition news. Roche acquisition of Spark Therapeutics According to the merger terms, Roche will offer to buy 100% of Spark Therapeutics for $ 114.50 […]

Continue reading …
Gene therapy company 4D Molecular Therapeutics raises $90m in new funding

California-based gene therapy company 4D Molecular Therapeutics (4DMT), which is focused on adeno-associated virus (AAV) gene therapy vector discovery and product development, has raised $90 million through a Series B financing round. Viking Global Investors led the new funding round in the gene therapy company with ArrowMark Partners, Janus Henderson Investors, The Biotechnology Value Fund, […]

Continue reading …